Next Generation Sequencing (NGS) Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, and the latest R&D initiatives is also available in the report.
Market Highlights – NGS Market
According to the detailed analysis of Market Research Future (MRFR), the global next-generation sequencing market is expected to reach a remarkable valuation at a striking CAGR over the forecast period (2018–2023).
The introduction of high throughput sequencing technology has created substantial changes in the sequencing process by providing speed and lessening sequencing cost. The technology is developing at a higher rate due to its application in agricultural, clinical, and forensic fields. it has helped to identify several clinical applications such as cancer, hereditary genetic disorders, and to detect the contagious disease.
Factors such as rising technological advancements, growing awareness, increasing acquisitions, and mergers among the market players to raise revenue for new product innovations are expected to contribute substantially to the global market share. Additionally, a rise in genome mapping programs is also likely to fuel the growth of the market exponentially. However, factors such as infrastructure, skilled employees who can manage and store huge amount of data properly, along with the high cost implicated in the technology are estimated to restrain the market growth over the forecast period.
Get Exclusive Sample Copy of “Next Generation Sequencing Market” Report @ https://www.marketresearchfuture.com/sample_request/6354
Key Players – NGS Market
The competitors have adopted diversified plans to increase their chances for success in the market. The creation of great competitive advantages is expected to aid in the development of the market. A substantial ascent in the number of promoters in the market is anticipated to shape a beneficial state of activities for the growth of the market in the forecasted period. The access to vital planned prospects imperative to the resultant stabilization of inflation is likely to produce a promising option for advancement in the forthcoming years. The growth of the market is influenced by the presence of factors that are stimulating the growth of the market. The need to create a sustainable competitive advantage has accelerated the progress of the market in the forecast period. The diversified consumer tastes and trends in the market are anticipated to lead to an escalated development rate in the market. The use of strategic tools to further the development of the market in the coming years.
Some of the key players in the global market for next-generation sequencing
- Agilent Technologies (US),
- BGI (China),
- Eurofins Scientific (Luxembourg),
- Illumina, Inc. (US),
- Macrogen Inc. (South Korea),
- Oxford Nanopore Technologies, Ltd. (UK),
- Pacific Biosciences of California, Inc. (US),
- PerkinElmer (US),
- QIAGEN N. V. (Germany), and
- Thermo Fisher Scientific, Inc. (the US).
February 18, 2019: QIAGEN N.V. has recently announced an agreement with the Ares Genetics in order to develop innovative bioinformatics and assay solutions to augment research targeting the global health challenges posed by antibiotic-resistant bacteria.
Regional Analysis – NGS Market
Based on the region, the global market for the next-generation sequencing market is analyzed in North America, Latin America, Asia Pacific, Europe, and the middle east and Africa.
North America is anticipated to account for the largest market share in the next-generation sequencing market over the review period. Factors such as an increase in consumer necessities and augmented competition among market players in the region through acquisitions and mergers are likely to drive the growth of the market over the forecast period. The growth in the number of resources and initiatives implemented by the government to reduce the cancer prevalence and to advance the healthcare sector is also likely to contribute to the market.
The European region is anticipated to hold the second-largest market share owing to the presence of ground-breaking next-generation sequencing technology, a very sophisticated and educated population that is taking an interest in next-generation technology (NGS). however, the diverse rules and regulations and a fragmented market can create challenges for the market growth over the forecast period, creating a disruption in terms of growth.
The market share in Asia-Pacific is also anticipated to witness growth in the forecast period owing to the access to most favorable treatment facilities and increasing demand for advanced technologies, higher adoption rate, enhancement in disposable income, and expanding investments by pharmaceutical companies in the market over the forecast period.
The next-generation sequencing market in the Middle East and Africa is projected to account for the smallest share of the next-generation sequencing market due to a weak healthcare sector, lack of technological knowledge and skilled workforce, and poor medical facilities. The middle east is likely to contribute substantially towards the market share.
Segments – NGS Market
The global next generation sequencing market has been segmented on the basis of technology, service and product, application, end user, and region.
On the basis of the type of technology, the market has been classified as whole genome sequencing, whole exome sequencing, CHIP sequencing, methyl sequencing, targeted resequencing, RNA sequencing and de novo sequencing.
On the basis of the type of service & product, the market has been classified as sample preparation, consumables, platforms and services for platforms, and sequencing services. The sample preparation segment is further sub-segmented into DNA fragmentation, end repair, A-tailing, size selection, library preparation & target enrichment, and quality control. The platforms and services for platforms are segmented into Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, and others. The sequencing services are segmented into exome & targeted re-sequencing and custom panels, RNA-seq, whole-genome sequencing, and de novo sequencing.
On the basis of application, the market has been classified as drug discovery, genetic screening, diagnostics, agriculture and animal research, and others.
On the basis of end users, the market has been segmented into academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/6354
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312